Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ralph Weissleder, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by Ralph Weissleder and Miles Miller.
Connection Strength

10.059
  1. Modular Nanoparticulate Prodrug Design Enables Efficient Treatment of Solid Tumors Using Bioorthogonal Activation. ACS Nano. 2018 12 26; 12(12):12814-12826.
    View in: PubMed
    Score: 0.827
  2. Near infrared imaging of Mer tyrosine kinase (MERTK) using MERi-SiR reveals tumor associated macrophage uptake in metastatic disease. Chem Commun (Camb). 2017 Dec 19; 54(1):42-45.
    View in: PubMed
    Score: 0.772
  3. Nano-palladium is a cellular catalyst for in vivo chemistry. Nat Commun. 2017 07 12; 8:15906.
    View in: PubMed
    Score: 0.749
  4. Prediction of Anti-cancer Nanotherapy Efficacy by Imaging. Nanotheranostics. 2017; 1(3):296-312.
    View in: PubMed
    Score: 0.748
  5. Imaging of anticancer drug action in single cells. Nat Rev Cancer. 2017 06 23; 17(7):399-414.
    View in: PubMed
    Score: 0.746
  6. Radiation therapy primes tumors for nanotherapeutic delivery via macrophage-mediated vascular bursts. Sci Transl Med. 2017 05 31; 9(392).
    View in: PubMed
    Score: 0.743
  7. Imaging the pharmacology of nanomaterials by intravital microscopy: Toward understanding their biological behavior. Adv Drug Deliv Rev. 2017 04; 113:61-86.
    View in: PubMed
    Score: 0.694
  8. Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle. Sci Transl Med. 2015 Nov 18; 7(314):314ra183.
    View in: PubMed
    Score: 0.668
  9. Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug. Nat Commun. 2015 Oct 27; 6:8692.
    View in: PubMed
    Score: 0.665
  10. Platinum compounds for high-resolution in vivo cancer imaging. ChemMedChem. 2014 Jun; 9(6):1131-5.
    View in: PubMed
    Score: 0.590
  11. Therapeutically reprogrammed nutrient signalling enhances nanoparticulate albumin bound drug uptake and efficacy in KRAS-mutant cancer. Nat Nanotechnol. 2021 07; 16(7):830-839.
    View in: PubMed
    Score: 0.244
  12. Macrophage imaging and subset analysis using single-cell RNA sequencing. Nanotheranostics. 2021; 5(1):36-56.
    View in: PubMed
    Score: 0.238
  13. Detecting Immune Response to Therapies Targeting PDL1 and BRAF by Using Ferumoxytol MRI and Macrin in Anaplastic Thyroid Cancer. Radiology. 2021 01; 298(1):123-132.
    View in: PubMed
    Score: 0.235
  14. In vivo microscopy reveals macrophage polarization locally promotes coherent microtubule dynamics in migrating cancer cells. Nat Commun. 2020 07 14; 11(1):3521.
    View in: PubMed
    Score: 0.231
  15. Efficient blockade of locally reciprocated tumor-macrophage signaling using a TAM-avid nanotherapy. Sci Adv. 2020 May; 6(21):eaaz8521.
    View in: PubMed
    Score: 0.228
  16. Improving nanotherapy delivery and action through image-guided systems pharmacology. Theranostics. 2020; 10(3):968-997.
    View in: PubMed
    Score: 0.222
  17. Single-Cell Intravital Microscopy of Trastuzumab Quantifies Heterogeneous in vivo Kinetics. Cytometry A. 2020 05; 97(5):528-539.
    View in: PubMed
    Score: 0.217
  18. Quantitative Imaging of Tumor-Associated Macrophages and Their Response to Therapy Using 64Cu-Labeled Macrin. ACS Nano. 2018 12 26; 12(12):12015-12029.
    View in: PubMed
    Score: 0.207
  19. Heterogeneity of macrophage infiltration and therapeutic response in lung carcinoma revealed by 3D organ imaging. Nat Commun. 2017 02 08; 8:14293.
    View in: PubMed
    Score: 0.182
  20. Reduced Proteolytic Shedding of Receptor Tyrosine Kinases Is a Post-Translational Mechanism of Kinase Inhibitor Resistance. Cancer Discov. 2016 Apr; 6(4):382-99.
    View in: PubMed
    Score: 0.171
  21. Advances in measuring single-cell pharmacology in vivo. Drug Discov Today. 2015 Sep; 20(9):1087-92.
    View in: PubMed
    Score: 0.162
  22. Single-cell pharmacokinetic imaging reveals a therapeutic strategy to overcome drug resistance to the microtubule inhibitor eribulin. Sci Transl Med. 2014 Nov 05; 6(261):261ra152.
    View in: PubMed
    Score: 0.155
  23. Single cell imaging of Bruton's tyrosine kinase using an irreversible inhibitor. Sci Rep. 2014 Apr 24; 4:4782.
    View in: PubMed
    Score: 0.150
  24. p53 dynamics vary between tissues and are linked with radiation sensitivity. Nat Commun. 2021 02 09; 12(1):898.
    View in: PubMed
    Score: 0.060
  25. Receptor-Driven ERK Pulses Reconfigure MAPK Signaling and Enable Persistence of Drug-Adapted BRAF-Mutant Melanoma Cells. Cell Syst. 2020 11 18; 11(5):478-494.e9.
    View in: PubMed
    Score: 0.059
  26. Site occupancy calibration of taxane pharmacology in live cells and tissues. Proc Natl Acad Sci U S A. 2018 11 27; 115(48):E11406-E11414.
    View in: PubMed
    Score: 0.051
  27. In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy. Sci Transl Med. 2017 05 10; 9(389).
    View in: PubMed
    Score: 0.046
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.